David Kelly
Direttore Finanziario/CFO presso ArraVasc Ltd.
Posizioni attive di David Kelly
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
ArraVasc Ltd.
 ArraVasc Ltd. Medical SpecialtiesHealth Technology ArraVasc Ltd. develops novel solutions for the treatment of complex coronary artery disease. The private company is based in Ballybrit, Ireland. The Irish company was founded in 2005 by Antonio Colombo, Ascher Shmulewitz. | Direttore Finanziario/CFO | - | - |
Storia della carriera di David Kelly
Precedenti posizioni note di David Kelly
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ARYZTA AG | Corporate Officer/Principal | - | - |
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | - | - |
Chanelle Pharmaceuticals Manufacturing Ltd.
 Chanelle Pharmaceuticals Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Chanelle Pharmaceuticals Manufacturing Ltd. engages in the development, production, marketing, and distribution of generic animal pharmaceutical products. Its veterinary products include Anthelmintics, Antibiotics, Sedatives, NSAIDs, Cardiovascular, Ectoparasiticides, and Anti-Epileptic drugs. The company was founded on June 14, 1984 and is headquartered in Loughrea, Ireland. | Corporate Officer/Principal | - | - |
Cappella, Inc.
 Cappella, Inc. Pharmaceuticals: MajorHealth Technology Cappella, Inc. operates as a medical device company, which develops novel solutions for the treatment of complex coronary artery disease (CAD) and specifically bifurcation vascular disease. The company was founded by Antonio Columbo and Ascher Shmulewitz in 2004 and is headquartered in Boston, MA. | Direttore Finanziario/CFO | - | - |
| Treasurer | - | - |
Statistiche
Distribuzione geografica
| Irlanda | 4 |
| Stati Uniti | 2 |
| Svizzera | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Director of Finance/CFO | 2 |
| Treasurer | 1 |
Settori
| Health Technology | 5 |
| Retail Trade | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| ARYZTA AG | Retail Trade |
| Aziende private | 3 |
|---|---|
Cappella, Inc.
Cappella, Inc. Pharmaceuticals: MajorHealth Technology Cappella, Inc. operates as a medical device company, which develops novel solutions for the treatment of complex coronary artery disease (CAD) and specifically bifurcation vascular disease. The company was founded by Antonio Columbo and Ascher Shmulewitz in 2004 and is headquartered in Boston, MA. | Health Technology |
ArraVasc Ltd.
ArraVasc Ltd. Medical SpecialtiesHealth Technology ArraVasc Ltd. develops novel solutions for the treatment of complex coronary artery disease. The private company is based in Ballybrit, Ireland. The Irish company was founded in 2005 by Antonio Colombo, Ascher Shmulewitz. | Health Technology |
Chanelle Pharmaceuticals Manufacturing Ltd.
Chanelle Pharmaceuticals Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Chanelle Pharmaceuticals Manufacturing Ltd. engages in the development, production, marketing, and distribution of generic animal pharmaceutical products. Its veterinary products include Anthelmintics, Antibiotics, Sedatives, NSAIDs, Cardiovascular, Ectoparasiticides, and Anti-Epileptic drugs. The company was founded on June 14, 1984 and is headquartered in Loughrea, Ireland. | Health Technology |
- Borsa valori
- Insiders
- David Kelly
- Esperienza
